167 related articles for article (PubMed ID: 28243398)
1. Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma.
Hodeib H; ELshora O; Selim A; Sabry NM; El-Ashry HM
Electron Physician; 2017 Jan; 9(1):3492-3498. PubMed ID: 28243398
[TBL] [Abstract][Full Text] [Related]
2. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
[TBL] [Abstract][Full Text] [Related]
3. Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients.
El-Shayeb AF; El-Habachi NM; Mansour AR; Zaghloul MS
Medicine (Baltimore); 2021 Apr; 100(17):e25112. PubMed ID: 33907088
[TBL] [Abstract][Full Text] [Related]
4. The value of serum midkine level in diagnosis of hepatocellular carcinoma.
Shaheen KY; Abdel-Mageed AI; Safwat E; AlBreedy AM
Int J Hepatol; 2015; 2015():146389. PubMed ID: 25737783
[TBL] [Abstract][Full Text] [Related]
5. Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma.
Fouad SA; Mohamed NA; Fawzy MW; Moustafa DA
Hepat Mon; 2015 Sep; 15(9):e30753. PubMed ID: 26500684
[TBL] [Abstract][Full Text] [Related]
6. The possible role of Dickkopf-1, Golgi protein- 73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study.
N Zekri AR; El Kassas M; Salam ESE; Hassan RM; Mohanad M; Gabr RM; M Lotfy M; Abdel-Zaher RAT; Bahnassy AA; Ahmed OS
Sci Rep; 2020 Mar; 10(1):5156. PubMed ID: 32198440
[TBL] [Abstract][Full Text] [Related]
7. Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis.
Lu Q; Li J; Cao H; Lv C; Wang X; Cao S
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039435
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis.
Abdel-Hafiz SM; Hamdy HE; Khorshed FM; Aboushousha TS; Safwat G; Saber MA; Seleem M; Soliman AH
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1021-1027. PubMed ID: 29693976
[TBL] [Abstract][Full Text] [Related]
9. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
Nabih MI; Aref WM; Fathy MM
Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.
Zhu WW; Guo JJ; Guo L; Jia HL; Zhu M; Zhang JB; Loffredo CA; Forgues M; Huang H; Xing XJ; Ren N; Dong QZ; Zhou HJ; Ren ZG; Zhao NQ; Wang XW; Tang ZY; Qin LX; Ye QH
Clin Cancer Res; 2013 Jul; 19(14):3944-54. PubMed ID: 23719264
[TBL] [Abstract][Full Text] [Related]
11. Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
Shang S; Plymoth A; Ge S; Feng Z; Rosen HR; Sangrajrang S; Hainaut P; Marrero JA; Beretta L
Hepatology; 2012 Feb; 55(2):483-90. PubMed ID: 21953299
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Plasma Osteopontin Level as a Biomarker of Hepatocellular Carcinoma.
Salem M; Atti SA; Raziky ME; Darweesh SK; Sharkawy ME
Gastroenterology Res; 2013 Oct; 6(5):191-199. PubMed ID: 27785253
[TBL] [Abstract][Full Text] [Related]
14. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
[TBL] [Abstract][Full Text] [Related]
15. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker.
Christou C; Stylianou A; Gkretsi V
Cells; 2024 Jan; 13(2):. PubMed ID: 38247828
[TBL] [Abstract][Full Text] [Related]
16. Serum midkine levels for the diagnosis and assessment of response to interventional therapy in patients with hepatocellular carcinoma.
Zheng L; Li H; Huang J; Shin J; Luo S; Guo C; Zhao Y; Li F
J Interv Med; 2021 Feb; 4(1):39-45. PubMed ID: 34805946
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma.
Abu El Makarem MA; Abdel-Aleem A; Ali A; Saber R; Shatat M; Rahem DA; Sayed D
Ann Hepatol; 2011; 10(3):296-305. PubMed ID: 21677331
[TBL] [Abstract][Full Text] [Related]
18. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients.
Mashaly AH; Anwar R; Ebrahim MA; Eissa LA; El Shishtawy MM
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1503-1508. PubMed ID: 29936723
[TBL] [Abstract][Full Text] [Related]
20. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
Ouda SM; Khairy AM; Sorour AE; Mikhail MN
Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
